Better Medicine, Faster
Founded in 2023, Intrepid Labs is transforming drug formulation through Valiant™, a modular AI and robotics-powered platform. Valiant compresses months of trial-and-error into days, delivering safer, more effective drug formats. With a team rooted in formulation science and automation, Intrepid enables faster, smarter paths from molecule to patient, making better medicine possible, faster.
Formulation is failing us
Formulation is a critical but overlooked step in drug development. Today’s approach is too slow, narrow, and risky - causing delays, failures, and missed opportunities. Developers can’t explore the full range of drug delivery options, leaving promising molecules stuck in suboptimal formats. The result? Lost time, higher costs, sub-optimal delivery formats or therapies that never reach patients.
Formulation, reimagined through AI and automation
Intrepid’s Valiant™ platform unlocks parallelized, AI-guided formulation design. By automating R&D with robotics and real-time data modeling, Intrepid compresses months of work into days. Drug developers can now explore optimal delivery formats early, improving clinical outcomes, patient convenience, and development speed. Valiant enables intelligent formulation that scales with the pace of modern pipelines.
Backing the builders of better drug deliveries
AVANT BIO led Intrepid Labs’ $7M seed round to help scale its team, platform, and commercial momentum. Our network and operating expertise will accelerate partnerships and go-to-market execution. We believe smarter formulation is foundational to next-gen therapeutics—and Intrepid is setting the pace. Together, we’re building the future of drug delivery.
Formulation is failing us
Formulation is a critical but overlooked step in drug development. Today’s approach is too slow, narrow, and risky - causing delays, failures, and missed opportunities. Developers can’t explore the full range of drug delivery options, leaving promising molecules stuck in suboptimal formats. The result? Lost time, higher costs, sub-optimal delivery formats or therapies that never reach patients.
Formulation, reimagined through AI and automation
Intrepid’s Valiant™ platform unlocks parallelized, AI-guided formulation design. By automating R&D with robotics and real-time data modeling, Intrepid compresses months of work into days. Drug developers can now explore optimal delivery formats early, improving clinical outcomes, patient convenience, and development speed. Valiant enables intelligent formulation that scales with the pace of modern pipelines.
Backing the builders of better drug deliveries
AVANT BIO led Intrepid Labs’ $7M seed round to help scale its team, platform, and commercial momentum. Our network and operating expertise will accelerate partnerships and go-to-market execution. We believe smarter formulation is foundational to next-gen therapeutics—and Intrepid is setting the pace. Together, we’re building the future of drug delivery.